These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Social norms and the evolution of drug regulation in the U.S.: implications for access to medications for HIV disease. Smith SR; Kirking DM AIDS Public Policy J; 1999; 14(3):105-16. PubMed ID: 10935047 [No Abstract] [Full Text] [Related]
63. Senator Royal Copeland. The medical and political career of a homeopathic physician. Davidson JR; Dantas F Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):4-10. PubMed ID: 18767595 [No Abstract] [Full Text] [Related]
64. Triplicate prescription in New York: history and review. Farnsworth PB N Y State J Med; 1991 Nov; 91(11 Suppl):5S-8S. PubMed ID: 1771060 [No Abstract] [Full Text] [Related]
65. Post-marketing surveillance and adverse drug reactions. Shani S Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310 [No Abstract] [Full Text] [Related]
66. Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament. Mirowski P Soc Stud Sci; 2007 Apr; 37(2):311-27. PubMed ID: 17645149 [No Abstract] [Full Text] [Related]
67. The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co. McFadyen RE Bull Hist Med; 1979; 53(2):159-69. PubMed ID: 389316 [No Abstract] [Full Text] [Related]
68. Unapproved generics. A generation of confusion. Stewart D Am Pharm; 1980 Nov; NS20(11):12-7. PubMed ID: 7006354 [No Abstract] [Full Text] [Related]
69. Primer on medical device regulation. Part I. History and background. Monsein LH Radiology; 1997 Oct; 205(1):1-9. PubMed ID: 9314952 [No Abstract] [Full Text] [Related]
70. Food and drug regulation after 75 years. Hayes AH JAMA; 1981 Sep; 246(11):1223-6. PubMed ID: 7021890 [No Abstract] [Full Text] [Related]
71. [70 years of the State Institute for Drug Control]. Drábek P; Hanzlícek Z Cesk Farm; 1988 Sep; 37(7):331-5. PubMed ID: 3058327 [No Abstract] [Full Text] [Related]
72. The reformation of animal drug law: the impact of 1996. Lambert EI Food Drug Law J; 1997; 52(3):277-89. PubMed ID: 10343026 [No Abstract] [Full Text] [Related]
73. Dinitrophenol and obesity: an early twentieth-century regulatory dilemma. Colman E Regul Toxicol Pharmacol; 2007 Jul; 48(2):115-7. PubMed ID: 17475379 [TBL] [Abstract][Full Text] [Related]
74. Regulatory aspects of investigational new drugs. Arbit HM Am J Hosp Pharm; 1978 Jan; 35(1):81-5. PubMed ID: 341700 [TBL] [Abstract][Full Text] [Related]
75. The Food and Drug Administration and the backward motion toward the source. Kennedy D Public Health Rep; 1978; 93(6):607-15. PubMed ID: 362468 [No Abstract] [Full Text] [Related]
76. The Food and Drug Administration: how those regulations came to be. Ziporyn T JAMA; 1985 Oct; 254(15):2037-9, 2043-6. PubMed ID: 3900441 [No Abstract] [Full Text] [Related]
77. FDA centennial. Kennedy D Science; 2006 Apr; 312(5770):19. PubMed ID: 16601155 [No Abstract] [Full Text] [Related]
78. Dr. Harvey Wiley's brainchild, 75 years later. Goyan JE J Assoc Off Anal Chem; 1981 Mar; 64(2):256-9. PubMed ID: 7014549 [No Abstract] [Full Text] [Related]
79. Regulating compounding pharmacies after NECC. Outterson K N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357 [No Abstract] [Full Text] [Related]
80. General considerations for studies of the metabolism of drugs and other chemicals. Glocklin VC Drug Metab Rev; 1982; 13(6):929-39. PubMed ID: 6754317 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]